T1	Chemical 25 33	CUDC-101 
T3	Gene_or_protein 78 81	p21 
T4	Gene_or_protein 86 96	E-cadherin 
T5	Gene_or_protein 136 140	XIAP 
T6	Gene_or_protein 143 152	b-catenin 
T7	Gene_or_protein 155 165	N-cadherin 
T8	Gene_or_protein 172 180	Vimentin 
T9	Pharmacodynamic_phenotype 4 33	anticancer effect of CUDC-101
T12	Gene_or_protein 125 133	survivin
T2	Phenotype 54 81	increased expression of p21
T10	Phenotype 54 77;86 96	increased expression of E-cadherin
T11	Phenotype 103 133	reduced expression of survivin
T13	Phenotype 103 124;136 140	reduced expression of XIAP
T14	Phenotype 103 124;143 152	reduced expression of b-catenin
T15	Phenotype 103 124;155 165	reduced expression of N-cadherin
T16	Phenotype 103 124;172 180	reduced expression of Vimentin
R1	isAssociatedWith Arg1:T9 Arg2:T10	
R2	isAssociatedWith Arg1:T9 Arg2:T2	
R3	isAssociatedWith Arg1:T9 Arg2:T11	
R4	isAssociatedWith Arg1:T9 Arg2:T13	
R5	isAssociatedWith Arg1:T9 Arg2:T14	
R6	isAssociatedWith Arg1:T9 Arg2:T15	
R7	isAssociatedWith Arg1:T9 Arg2:T16	
